These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 18953049)

  • 1. Is thrombogenesis related to residual platelet function in ischaemic heart disease?
    Pastor-Pérez FJ; Marín F; Manzano-Fernández S; Lip GY
    Eur Heart J; 2008 Dec; 29(24):3065; author reply 3065-6. PubMed ID: 18953049
    [No Abstract]   [Full Text] [Related]  

  • 2. Enoxaparin in elective percutaneous coronary intervention.
    Hamon M; Riddell JW
    N Engl J Med; 2006 Dec; 355(26):2788-9; author reply 2790-1. PubMed ID: 17195309
    [No Abstract]   [Full Text] [Related]  

  • 3. Enoxaparin in elective percutaneous coronary intervention.
    Schuler J; Altenberger J; Heigert M
    N Engl J Med; 2006 Dec; 355(26):2789-90; author reply 2790-1. PubMed ID: 17193723
    [No Abstract]   [Full Text] [Related]  

  • 4. Enoxaparin in elective percutaneous coronary intervention.
    Bhala N
    N Engl J Med; 2006 Dec; 355(26):2788; author reply 2790-1. PubMed ID: 17192548
    [No Abstract]   [Full Text] [Related]  

  • 5. Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.
    Rubboli A; Halperin JL
    Thromb Haemost; 2008 Nov; 100(5):752-3. PubMed ID: 18989515
    [No Abstract]   [Full Text] [Related]  

  • 6. Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody.
    Roldán V; Marín F
    Thromb Haemost; 2008 Nov; 100(5):754-5. PubMed ID: 18989516
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombin as a common downstream target blocking both platelet and monocyte activation.
    Santilli F; Davì G
    Thromb Haemost; 2009 Feb; 101(2):220-1. PubMed ID: 19190800
    [No Abstract]   [Full Text] [Related]  

  • 8. Enoxaparin in elective percutaneous coronary intervention.
    Karthikeyan G
    N Engl J Med; 2006 Dec; 355(26):2789; author reply 2790-1. PubMed ID: 17195310
    [No Abstract]   [Full Text] [Related]  

  • 9. Enoxaparin in elective percutaneous coronary intervention.
    Pasceri V
    N Engl J Med; 2006 Dec; 355(26):2789; author reply 2790-1. PubMed ID: 17195306
    [No Abstract]   [Full Text] [Related]  

  • 10. Hazard--the anticoagulation bridge or just go transradial.
    Gilchrist IC
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):48-9. PubMed ID: 19089937
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antithrombotic treatment after coronary stenting in patients with an indication to oral anticoagulation: what are the possible strategies?].
    Rubboli A; Di Pasquale G
    G Ital Cardiol (Rome); 2006 Jan; 7(1):68-73. PubMed ID: 16528965
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety and tolerability of hirudins in percutaneous coronary intervention and the risk of Kounis syndrome.
    Kounis NG; Kounis SA; Kounis GN; Hahalis G
    Catheter Cardiovasc Interv; 2009 Mar; 73(4):584-5. PubMed ID: 19085914
    [No Abstract]   [Full Text] [Related]  

  • 13. Three cases of left main stem thrombus complicating PCI: the role of FilterWire protection for the virgin territory.
    Wu EB; Chan WW; Yu CM
    J Invasive Cardiol; 2008 Oct; 20(10):E283-7. PubMed ID: 18830007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Facilitated angioplasty: neither black nor white].
    Sánchez PL; Fernández-Avilés F
    Rev Esp Cardiol; 2005 Feb; 58(2):111-8. PubMed ID: 15743555
    [No Abstract]   [Full Text] [Related]  

  • 15. Anticoagulation in the cath lab: a contemporary approach. Introduction.
    Kandzari DE
    Rev Cardiovasc Med; 2006; 7 Suppl 3():S1-2. PubMed ID: 17224878
    [No Abstract]   [Full Text] [Related]  

  • 16. A prospective multicentre observational study on the management of patients on oral anticoagulation undergoing coronary artery stenting: rationale and design of the ongoing warfarin and coronary stenting (WAR-STENT) registry.
    Rubboli A; Bolognese L; Di Pasquale G; Galvani M; La Vecchia L; Maggioni AP
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):200-3. PubMed ID: 19377385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on dual antiplatelet therapy for percutaneous coronary intervention.
    Prasad A; Holmes DR
    Heart; 2009 Jun; 95(11):861-5. PubMed ID: 19372090
    [No Abstract]   [Full Text] [Related]  

  • 18. Is the glass 97% full, or 3% empty? Reinfarction and stent thrombosis after STEMI.
    Morrison DA
    Catheter Cardiovasc Interv; 2009 Apr; 73(5):635-6. PubMed ID: 19309703
    [No Abstract]   [Full Text] [Related]  

  • 19. Bleeding complications with PCI.
    Satler LF
    Catheter Cardiovasc Interv; 2005 Mar; 64(3):373-4. PubMed ID: 15736243
    [No Abstract]   [Full Text] [Related]  

  • 20. Editor's message.
    Shaw RE
    J Invasive Cardiol; 2010 Jun; 22(6):A6. PubMed ID: 20533622
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.